[ABT] Abbott Laboratories


Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.


Price: 38.41 Change: 0.12 (0.31%)
Ext. hours: Change: 0 (0%)

chart ABT

Refresh chart

Strongest Trends Summary For ABT

ABT is in the long-term up 85% in 3 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome, intrahepatic cholestasis or depressive symptoms, gynecological disorders, dyslipidemia, hypertension, hypothyroidism, pain, fever, and inflammation; and regulates physiological rhythm of the colon, as well as provides hormone replacement therapy and anti-infective and influenza vaccines. The company?s Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification,

Fundamental Ratios
Shares Outstanding EPS0.94 EPS Growth - 4 Quarters1349.62% EPS Growth - Q/Q238.84%
EPS Growth - Y/Y-44.39% Sales Growth - 4 Quarters -18.92% Sales Growth - Q/Q-7.43% P/E51.29
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA9.75% ROE19.21% ROI12.44%
Current Ratio2.17 Quick Ratio1.89 Long Term Debt/Equity0.55 Debt Ratio0.42
Gross Margin55.74% Operating Margin13.95% Net Profit Margin20.6% Dividend Payout Ratio-32.44%
Dividend Yield
Fundamental Data
Cash From Financing Activities-550 M Cash From Investing Activities-205 M Cash From Operating Activities2 M Gross Profit2.95 B
Net Profit784 M Operating Profit729 M Total Assets43.1 B Total Current Assets19.99 B
Total Current Liabilities9.21 B Total Debt8.46 B Total Liabilities21.22 B Total Revenue5.17 B
Technical Data
High 52 week79.73 Low 52 week53.74 Last close75.97 Last change-0.82%
RSI36.28 Average true range1.51 Beta0.56 Volume3.81 M
Simple moving average 20 days-1.58% Simple moving average 50 days-2.29% Simple moving average 200 days14.05%
Performance Data
Performance Week-0.63% Performance Month4.24% Performance Quart1.37% Performance Half29.53%
Performance Year36.11% Performance Year-to-date22.22% Volatility daily1.12% Volatility weekly2.5%
Volatility monthly5.12% Volatility yearly17.75% Relative Volume228.71% Average Volume5.53 M
New High New Low


2019-06-26 17:43:06 | Abbott Ireland Financing DAC -- Moody's announces completion of a periodic review of ratings of Abbott Laboratories

2019-06-25 10:32:02 | Abbvie Decides to Acquire Allergan

2019-06-25 10:14:02 | AbbVie to Buy Botox-Maker Allergan, Look Ahead to G-20

2019-06-25 09:10:40 | Allergan Is a $63 Billion Botox Job for AbbVie

2019-06-25 00:00:25 | Smith & Nephew directors discussed US listing to boost CEO pay

2019-06-24 09:00:00 | Nutrition Is the Missing Ingredient in Home Health Today, New Study Shows

2019-06-19 09:00:00 | Abbott Hosts Conference Call for Second-Quarter Earnings

2019-06-19 08:00:00 | Is Abbott Laboratories a Buy?

2019-06-19 07:34:09 | How Do Rate Cuts Impact Healthcare Stocks?

2019-06-18 17:50:09 | Abbott ABT Outpaces Stock Market Gains: What You Should Know

2019-06-17 12:00:00 | CARE, Abbott and the Abbott Fund Launch Partnership to Address Noncommunicable Diseases NCDs in Humanitarian Settings

2019-06-17 08:00:00 | Abbott Launches First-ever Rapid Point-of-Care HbA1c Test to Aid in the Diagnosis of Diabetes

2019-06-17 07:40:11 | Abbott ABT Hits New 52-Week High on Solid Growth Drivers

2019-06-14 10:45:00 | Abbott Declares 382?? Consecutive Quarterly Dividend

2019-06-13 09:00:01 | Abbott ABT Moves to Buy: Rationale Behind the Upgrade

2019-06-13 09:00:00 | New Survey Shows Millennials Can Help Avoid Blood Shortages

2019-06-12 08:28:15 | Traders Look to Buy Global Health Care Stocks

2019-06-10 17:45:09 | Abbott ABT Outpaces Stock Market Gains: What You Should Know

2019-06-10 16:40:40 | Here’s What Hedge Funds Think About Abbott Laboratories ABT

2019-06-10 09:38:01 | The Zacks Analyst Blog Highlights: Mastercard, Disney, Abbott, Workday and Sun Life

2019-06-09 07:00:00 | Where Will Abbott Laboratories Be in 10 Years?

2019-06-08 13:00:01 | Abbott device helps in cutting blood sugar in type 2 diabetics - study

2019-06-08 13:00:00 | New Data Show Use of Abbott's FreeStyle® Libre System Significantly Reduces HbA1c Levels in People Living with Type 2 Diabetes

2019-06-07 13:09:05 | Top Research Reports for Mastercard, Disney & Abbott

2019-06-06 09:30:01 | Is Abbott Laboratories ABT Outperforming Other Medical Stocks This Year?

2019-06-04 17:45:09 | Abbott ABT Gains But Lags Market: What You Should Know

2019-06-04 11:47:03 | Abbott ABT Grows on EPD Amid Rhythm Management Challenges

2019-06-04 08:01:32 | See what the IHS Markit Score report has to say about Gannett Co Inc.

2019-06-03 14:15:54 | Did Abbott Laboratories NYSE:ABT Use Debt To Deliver Its ROE Of 8.3%?

2019-06-01 21:08:08 | Here is the 18th Most Popular Stock Among Hedge Funds

2019-05-29 17:50:09 | Abbott ABT Stock Moves -0.05%: What You Should Know

2019-05-29 09:31:49 | The Top Health Care Companies in the World

2019-05-24 13:44:27 | The highest-paid CEOs by state

2019-05-24 12:21:43 | One sector is making a comeback amid market volatility

2019-05-23 17:45:09 | Abbott ABT Dips More Than Broader Markets: What You Should Know

2019-05-22 11:27:00 | 3 Dividend Aristocrats to Buy and Hold Forever

2019-05-21 10:45:00 | TRILUMINATE Study Shows Treatment with Abbott's First-of-its-Kind Minimally Invasive Device Reduces Tricuspid Heart Valve Leaks

2019-05-18 10:25:49 | Should Abbott Laboratories NYSE:ABT Be Part Of Your Dividend Portfolio?

2019-05-17 09:30:01 | Why Is Abbott ABT Up 3.6% Since Last Earnings Report?

2019-05-16 08:00:00 | New ZonePerfect® Keto is 100% #TrueKeto with the Proven Blend of Macros for Effective Results

2019-05-15 07:18:00 | Nearly 9 out of 10 College Students with Student Debt Say It's Important to Find a Company That Offers Loan Relief

2019-05-15 05:34:09 | Bull of the Day: Penumbra PEN

2019-05-14 09:00:00 | Abbott Partners With NIH On BRAIN Initiative to Advance Research for Neurological Disorders

2019-05-13 14:06:08 | Is Pinterest a compelling buy? Is Abbott heading to new highs? The desk answers viewer questions

2019-05-13 10:37:02 | Abbott Rides on Strong CGM, Poor Rhythm Management Ails

2019-05-10 09:00:01 | Abbott ABT Upgraded to Buy: What Does It Mean for the Stock?

2019-05-09 17:56:00 | Here are the stocks to buy if an all-out U.S.-China trade war erupts, says Goldman

2019-05-09 10:28:02 | The Zacks Analyst Blog Highlights: Verizon, Abbott, Illinois Tool Works, Moody's and Baker Hughes

2019-05-08 14:03:06 | Top Stock Reports for Verizon, Abbott & Illinois Tool Works

2019-05-08 11:35:03 | Haemonetics HAE Q4 Earnings Top Mark, Operating Margin Up